With a net worth of $12.6 billion, Patrick Soon-Shiong, MD, is the world's richest doctor, the richest American in the healthcare industry, and the 96th-richest person on the planet in 2015 according to Forbes.
And just in August, the 63-year-old became $1.1 billion richer — from a move he'd made only eight months prior, according to Bloomberg…
You see, a vast source of Soon-Shiong's wealth comes from biotech investing. The son of Chinese immigrants to South Africa, Soon-Shiong founded two drug companies in the 1980s. He sold Abraxis and American Pharmaceutical Partners for a combined $9.1 billion. Currently, Soon-Shiong holds eight investments in these five biotech companies:
|Feb 4, 2015||Zoom||$30M Series C||Personal Investment|
|Oct 1, 2014||Keyssa||$25M Series C||NantWorks|
|Jul 18, 2014||NantMobile||$30M Venture (Lead)||Personal Investment|
|Nov 29, 2013||Fluential||$2M Series A (Lead)||Personal Investment|
|Sep 24, 2013||Zoom||$6.5M Series B||Personal Investment|
|Jun 6, 2013||Prizeo||$2.5M Seed||Personal Investment|
|Jul 1, 2011||Keyssa||$5M Series B||NantWorks|
|May 1, 2010||Keyssa||$2M Series A||NantWorks|
*Data according to CrunchBase.
On Aug. 6, Soon-Shiong realized a $1.1 billion gain on an investment he'd made right before Christmas.
It proved to be one of the biggest biotech initial public offerings (IPOs) in recent memory — a holiday gift that kept on giving…
On July 28, NantKwest opened on the Nasdaq at $37 a share after floating 8.3 million shares at $25. That was well over the price talk of 7 million shares at $20-$23. It made the firm the largest biotech in the last decade, with an initial market cap of $2.6 billion, according to Renaissance Capital.
By Aug. 6, NK closed at $28.96 a share. According to Bloomberg Billionaires Index data (which assumes all shares were bought for the same price), that means Cambridge booked a ten-figure gain on its investment.
You Don't Have to Be Rich to Benefit from Biotech Investing
Soon-Shiong is capitalizing on a booming biotech sector.
But you don't have to be a billionaire to make money in the sector…
Even after a sell-off hit global markets hard on Aug. 24, the Nasdaq Biotechnology Index had gained 7.44% this year as of Aug. 25. That compares to a 9.28% downturn for the S&P 500 in the same period. And prior to "Black Monday," the biotech ETF was up more than 29% over the last 12 months, to the S&P's comparatively-paltry 0.81% climb.
Watch the following video for five easy steps to improve your biotech investing success. It'll show you how you can easily lower your risk and raise your profits immediately:
- Forbes: The World's Billionaires — Patrick Soon-Shiong
- Bloomberg: Soon-Shiong Harvests $1.1 Billion Biotech Profit in Eight Months
- CrunchBase: Patrick Soon-Shiong Investments